DRH1

Serial Number 88729959
Registration 6106257
700

Registration Progress

Application Filed
Dec 17, 2019
Under Examination
Approved for Publication
May 5, 2020
Published for Opposition
May 5, 2020
Registered
Jul 21, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-21)
Due: Jul 21, 2026 252 days

Trademark Image

DRH1

Basic Information

Serial Number
88729959
Registration Number
6106257
Filing Date
December 17, 2019
Registration Date
July 21, 2020
Published for Opposition
May 5, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 21, 2020
Registration
Registered
Classes
001 005

Rights Holder

Abviris Deutschland GmbH

16
Address
Beimoorkamp 6
Ahrensburg 22926
DE

Ownership History

Abviris Deutschland GmbH

Original Applicant
16
Ahrensburg DE

Abviris Deutschland GmbH

Owner at Publication
16
Ahrensburg DE

Abviris Deutschland GmbH

Original Registrant
16
Ahrensburg DE

Legal Representation

Attorney
Dean Amburn

USPTO Deadlines

Next Deadline
252 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-07-21)
Due Date
July 21, 2026
Grace Period Ends
January 21, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Jul 21, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Feb 5, 2021 CORV 5 REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED Loading...
Feb 3, 2021 PCGR O PETITION TO DIRECTOR GRANTED Loading...
Jan 14, 2021 APET A ASSIGNED TO PETITION STAFF Loading...
Aug 17, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 17, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 17, 2020 TPDR I TEAS PETITION TO DIRECTOR RECEIVED Loading...
Aug 17, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 21, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 5, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 5, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 15, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 2, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 31, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 31, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 26, 2020 ALIE A ASSIGNED TO LIE Loading...
Mar 19, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Mar 18, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Mar 18, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 18, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 18, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 18, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 18, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 18, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 16, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 20, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
protein in raw material form for scientific and medical research; proteins for detecting antibodies other than for medical use; diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Class 005
diagnostic agents for medical use, namely, tumor markers; diagnostic agents, preparations and substances for medical purposes; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use; in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer

Classification

International Classes
001 005